University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Across the country, one of every eight women will receive a breast cancer diagnosis in their lifetime. Kentucky’s diagnosis ...

Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.